|Articles|May 6, 2020

Is Congress doing enough to protect medical practices from COVID-19?

Anders Gilberg, senior vice president of government affairs for MGMA, talks about whether Congress’ actions have done enough for private practices to survive the COVID-19 coronavirus pandemic.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!

Related Content

ACIP presentation focuses on potential vaccine harm while ignoring benefits, physician expert says

ByRichard Payerchin

December 11th 2025

Flow Neuroscience gets approval for depression treatment device: ©Flow Neurosciences

Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment

ByTodd Shryock

December 11th 2025

Point-of-care testing, with Daniel Krajcik, D.O., MBA

ByAustin Littrell

December 11th 2025

Morning Medical Update © kwanchaichaiudom - stock.adobe.com

Sperm donor with rare cancer-causing gene fathered nearly 200 children in Europe; FDA’s priority voucher delivers first approval; mobile DNA and lung tumors – Morning Medical Update

ByAustin Littrell

December 11th 2025

Hospitals seeing rising costs: ©MedicalWorks - stock.adobe.com

Hospitals confront rising non-labor costs, workforce pressures and reimbursement challenges, Kaufman Hall reports

ByTodd Shryock

December 10th 2025

Latest CME

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Is Congress doing enough to protect medical practices from COVID-19?

Newsletter

Related Content

ACIP presentation focuses on potential vaccine harm while ignoring benefits, physician expert says

Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment

Point-of-care testing, with Daniel Krajcik, D.O., MBA

Sperm donor with rare cancer-causing gene fathered nearly 200 children in Europe; FDA’s priority voucher delivers first approval; mobile DNA and lung tumors – Morning Medical Update

Hospitals confront rising non-labor costs, workforce pressures and reimbursement challenges, Kaufman Hall reports

Latest CME

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

What's new in the American Diabetes Association's 2026 diabetes care standards

Hospitals confront rising non-labor costs, workforce pressures and reimbursement challenges, Kaufman Hall reports

Protected EHR time cuts after-hours work with little productivity loss, study finds

Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment

ABIM monopoly hurts osteopathic physicians overseeing residency, fellowship programs, lawsuit says